secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001040130-25-000064
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.06, 4.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express to restate FY2024, FY2023; investigation reveals revenue errors, former CEO/CFO out
--------------------------------------------------------------------------------

- Net sales overstated by ~$7.0M in FY2024 and ~$9.0M in FY2023 due to vendor payment misclassification; no net income impact.
- Investigation found Dec and Mar accelerated shipments: $133k and $1.1M revenue in wrong periods; $50 coupon and nepotism issues.
- Former CEO Sandra Campos, former CFO Robyn D'Elia, former Audit Chair Diana Purcel resigned; Board adopted remediation plan.
- Company expects to file FY2025 10-K by mid-October 2025; material weaknesses in internal controls to be reported.
- Also recorded $1.2M non-cash impairment of PCRX trade name; possible additional goodwill impairment due to stock decline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/0001040130-25-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013025000064/pets-20251001.htm
  HTML page:      https://secwatch.observer/filing/0001040130-25-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer